Literature DB >> 18286464

Meta-analyses of the incidence and prevalence of schizophrenia: conceptual and methodological issues.

Sukanta Saha1, David Chant, John McGrath.   

Abstract

While meta-analytic techniques are routine in the synthesis of data from randomized controlled trials, there are no clear guidelines on how best to summarize frequency data such as incidence and prevalence estimates. Based on data from two recent systematic reviews of the incidence and prevalence of schizophrenia, this paper explores some of the conceptual and methodological issues related to the meta-analyses of frequency estimates in epidemiology. Because variations in the incidence and prevalence of disorders such as schizophrenia can be informative, there is a case against collapsing data into one pooled estimate. Variations in frequency estimates can be displayed graphically, or summarized with quantiles around measures of central tendency. If pooled estimated are of interest, then researchers need to be aware that studies based on large samples will leverage greater weight on the pooled value. Based on systematic reviews of the incidence and prevalence of schizophrenia, we explore if these and related issues are of practical concern. When used with appropriate caution, meta-analysis can complement the synthesis of frequency data in epidemiology; however, researchers interested in variation should not rely on meta-analysis alone. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18286464      PMCID: PMC6878550          DOI: 10.1002/mpr.240

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  20 in total

Review 1.  Approaches to heterogeneity in meta-analysis.

Authors:  D B Petitti
Journal:  Stat Med       Date:  2001-12-15       Impact factor: 2.373

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Strengths and limitations of meta-analysis: larger studies may be more reliable.

Authors:  M D Flather; M E Farkouh; J M Pogue; S Yusuf
Journal:  Control Clin Trials       Date:  1997-12

4.  Invited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies.

Authors:  J A Berlin
Journal:  Am J Epidemiol       Date:  1995-08-15       Impact factor: 4.897

5.  A random-effects regression model for meta-analysis.

Authors:  C S Berkey; D C Hoaglin; F Mosteller; G A Colditz
Journal:  Stat Med       Date:  1995-02-28       Impact factor: 2.373

Review 6.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

Review 7.  Pooling research results: benefits and limitations of meta-analysis.

Authors:  J P Ioannidis; J Lau
Journal:  Jt Comm J Qual Improv       Date:  1999-09

Review 8.  Schizophrenia and migration: a meta-analysis and review.

Authors:  Elizabeth Cantor-Graae; Jean-Paul Selten
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

9.  Sex differences in the risk of schizophrenia: evidence from meta-analysis.

Authors:  Andre Aleman; René S Kahn; Jean-Paul Selten
Journal:  Arch Gen Psychiatry       Date:  2003-06

Review 10.  A systematic review of the prevalence of schizophrenia.

Authors:  Sukanta Saha; David Chant; Joy Welham; John McGrath
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

View more
  28 in total

1.  Life-threatening hyponatraemia and intramuscular olanzapine: the world's longest therapeutic trial.

Authors:  Jaspreet Phull; Steffan Davies
Journal:  BMJ Case Rep       Date:  2011-12-20

2.  Trends on schizophrenia admissions during the deinstitutionalisation process in Spain (1980-2004).

Authors:  Zuleika Saz-Parkinson; A Medel; P Cediel-García; J Castellote; C Bouza; J M Amate
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-10-24       Impact factor: 4.328

3.  Ethnic inequalities in the incidence of diagnosis of severe mental illness in England: a systematic review and new meta-analyses for non-affective and affective psychoses.

Authors:  Kristoffer Halvorsrud; James Nazroo; Michaela Otis; Eva Brown Hajdukova; Kamaldeep Bhui
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-09-03       Impact factor: 4.328

4.  Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study.

Authors:  S J Glatt; S D Chandler; C A Bousman; G Chana; G R Lucero; E Tatro; T May; J B Lohr; W S Kremen; I P Everall; M T Tsuang
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-09

Review 5.  Rates of homicide during the first episode of psychosis and after treatment: a systematic review and meta-analysis.

Authors:  Olav Nielssen; Matthew Large
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

6.  Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

Authors:  Johanna Koskinen; Johanna Löhönen; Hannu Koponen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2009-04-22       Impact factor: 9.306

7.  Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors.

Authors:  Amy M Kilbourne; Nancy E Morden; Karen Austin; Mark Ilgen; John F McCarthy; Gregory Dalack; Frederic C Blow
Journal:  Gen Hosp Psychiatry       Date:  2009-08-27       Impact factor: 3.238

8.  Major self-mutilation in the first episode of psychosis.

Authors:  Matthew Large; Nick Babidge; Doug Andrews; Philip Storey; Olav Nielssen
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

9.  Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia.

Authors:  Heidi Lempp; Graham Thornicroft; Morven Leese; Naomi Fearns; Helen Graves; Bernadette Khoshaba; Antonio Lasalvia; David Scott; Michele Tansella
Journal:  Qual Life Res       Date:  2009-05-10       Impact factor: 4.147

10.  Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples.

Authors:  Chad A Bousman; Gursharan Chana; Stephen J Glatt; Sharon D Chandler; Ginger R Lucero; Erick Tatro; Todd May; James B Lohr; William S Kremen; Ming T Tsuang; Ian P Everall
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.